hydroxychloroquine has been researched along with Orthopedic Disorders in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Childhood-onset systemic lupus erythematosus (SLE) is a severe, lifelong, multisystem autoimmune disease." | 1.51 | Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. ( Bijl, M; Bultink, IEM; de Leeuw, K; Dolhain, RJEM; Fritsch-Stork, R; Groot, N; Kamphuis, S; Shaikhani, D; Teng, YKO; Zirkzee, E, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trefond, L | 1 |
| Drumez, E | 1 |
| Andre, M | 1 |
| Costedoat-Chalumeau, N | 1 |
| Seror, R | 1 |
| Devaux, M | 1 |
| Dernis, E | 1 |
| Dieudonné, Y | 1 |
| El Mahou, S | 1 |
| Lanteri, A | 1 |
| Melki, I | 1 |
| Queyrel, V | 1 |
| Roumier, M | 1 |
| Schmidt, J | 1 |
| Barnetche, T | 1 |
| Thomas, T | 1 |
| Cacoub, P | 1 |
| Belot, A | 1 |
| Aumaitre, O | 1 |
| Richez, C | 1 |
| Hachulla, E | 1 |
| MartÃ-Carvajal, A | 1 |
| Ramon-Pardo, P | 1 |
| Javelle, E | 1 |
| Simon, F | 1 |
| Aldighieri, S | 1 |
| Horvath, H | 1 |
| Rodriguez-Abreu, J | 1 |
| Reveiz, L | 1 |
| Groot, N | 1 |
| Shaikhani, D | 1 |
| Teng, YKO | 1 |
| de Leeuw, K | 1 |
| Bijl, M | 1 |
| Dolhain, RJEM | 1 |
| Zirkzee, E | 1 |
| Fritsch-Stork, R | 1 |
| Bultink, IEM | 1 |
| Kamphuis, S | 1 |
| Chopra, A | 1 |
| Anuradha, V | 1 |
| Lagoo-Joshi, V | 1 |
| Kunjir, V | 1 |
| Salvi, S | 1 |
| Saluja, M | 1 |
| BUTTERWORTH, RF | 1 |
1 review available for hydroxychloroquine and Orthopedic Disorders
| Article | Year |
|---|---|
Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.
Topics: Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; Humans; Hydroxychloroquine; | 2017 |
4 other studies available for hydroxychloroquine and Orthopedic Disorders
| Article | Year |
|---|---|
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
Topics: Antirheumatic Agents; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Musculoskeletal Diseases; | 2021 |
Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Topics: Adolescent; Adult; Age of Onset; Aged; Antibodies, Antiphospholipid; Antirheumatic Agents; Child; Ch | 2019 |
Chikungunya virus aches and pains: an emerging challenge.
Topics: Alphavirus Infections; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chikungunya vi | 2008 |
The burning skin syndrome: treatment with hydroxychloroquine.
Topics: Chloroquine; Dermatology; Humans; Hydroxychloroquine; Musculoskeletal Diseases; Pain; Paresthesia; S | 1960 |